findmyKOL
Clinical trialNCT05996627RecruitingPhase 2Interventional

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

SponsorFred Hutchinson Cancer CenterEnrollment82Chronic Graft Versus Host Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Stephanie Lee, MD, MPH

    Fred Hutch/University of Washington Cancer Consortium

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope

    Duarte, California, United States

    Sunmin Park, MD
    Not, yet, recruiting
  • Moffitt Cancer Center

    Tampa, Florida, United States

    Joseph Pidala, MD, PhD
    Recruiting
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

    Corey Cutler, MD, MPH
    Recruiting
  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

    Doris Ponce, MD
    Recruiting
  • Fred Hutch/university of Washington Cancer Consortium

    Seattle, Washington, United States

    Stephanie Lee, MD, MPH
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 Dec 2023
Primary completion
30 Apr 2028
Completion
30 Nov 2028
Last update posted
4 Jun 2026
Registered enrollment
82
Registry id
NCT05996627

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.